Xiaoli Luo Selected Research

Xiaoli Luo Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 03/2016
3	Hypertension (High Blood Pressure) 01/2022 - 10/2018
3	Carcinoma (Carcinomatosis) 03/2019 - 01/2017
2	Diabetes Mellitus 01/2022 - 10/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 09/2018
2	Hypoxia (Hypoxemia) 04/2016 - 12/2008
2	Breast Neoplasms (Breast Cancer) 04/2016 - 03/2016
1	Heart Injuries 02/2022
1	Inflammation (Inflammations) 02/2022
1	Stroke (Strokes) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Leukemia 01/2022
1	Rheumatoid Arthritis 10/2021
1	Heart Failure 05/2021
1	Critical Illness (Critically Ill) 05/2021
1	Persistent Left Superior Vena Cava 01/2021
1	Infarction (Infarctions) 01/2021
1	Chylous Ascites 01/2021
1	Multiple Carboxylase Deficiency (Deficiency, Multiple Carboxylase) 05/2020
1	Rare Diseases (Rare Disease) 05/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2019
1	Pituitary Neoplasms (Pituitary Adenoma) 10/2019
1	Cross Infection (Nosocomial Infection) 01/2019
1	Hemorrhagic Shock 03/2018
1	Hemorrhage 03/2018
1	Hemothorax 03/2018
1	Nasopharyngeal Carcinoma 01/2018
1	Endolymphatic Hydrops 09/2017
1	Carcinogenesis 01/2017
1	Neoplasm Metastasis (Metastasis) 04/2016
1	Body Weight (Weight, Body) 01/2016
1	Malaria 01/2016
1	Hypercholesterolemia 06/2015
1	Asthma (Bronchial Asthma) 06/2015
1	Coronary Stenosis (Coronary Artery Stenosis) 04/2014
1	Sclerosis 01/2014

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 02/2022 - 09/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 02/2022 - 01/2018
2	Pharmaceutical PreparationsIBA 10/2021 - 01/2021
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 10/2018
2	AcidsIBA 05/2020 - 06/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 03/2016
2	Transcription Factors (Transcription Factor)IBA 04/2016 - 03/2016
1	Messenger RNA (mRNA)IBA 02/2022
1	RNA (Ribonucleic Acid)IBA 02/2022
1	Biological ProductsIBA 02/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	SaltsIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 10/2021
1	Metal-Organic FrameworksIBA 10/2021
1	pro-brain natriuretic peptide (1-76)IBA 05/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	abemaciclibIBA 01/2021
1	belnacasanIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Ligases (Synthetase)IBA 05/2020
1	Competitive Endogenous RNAIBA 10/2019
1	Circular RNAIBA 03/2019
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 10/2018
1	Dopamine Receptors (Dopamine Receptor)IBA 10/2018
1	SodiumIBA 10/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2018
1	Caspase 3 (Caspase-3)IBA 09/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Cancer VaccinesIBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	Long Noncoding RNAIBA 11/2017
1	AldosteroneIBA 09/2017
1	WW Domain-Containing OxidoreductaseIBA 01/2017
1	ChromatinIBA 04/2016
1	ElementsIBA 04/2016
1	Histone MethyltransferasesIBA 03/2016
1	GATA1 Transcription FactorIBA 03/2016
1	EnzymesIBA 03/2016
1	Histones (Histone)IBA 03/2016
1	Antihypertensive Agents (Antihypertensives)IBA 01/2016
1	artemisinin (artemisinine)IBA 01/2016
1	Monoclonal AntibodiesIBA 06/2015
1	SubtilisinIBA 06/2015
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 06/2015
1	LDL CholesterolIBA 06/2015
1	LipidsIBA 06/2015
1	PCSK9 InhibitorsIBA 06/2015
1	CarbonIBA 06/2015
1	GlycosphingolipidsIBA 06/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2015
1	Insulin (Novolin)FDA Link 04/2014
1	Capsules (Microcapsules)IBA 01/2014

Therapy/Procedure

3	Therapeutics 10/2021 - 09/2018
1	Transplantation 01/2022
1	Nursing Care 01/2022
1	Conservative Treatment 01/2021
1	Thoracotomy 01/2021
1	Artificial Respiration (Mechanical Ventilation) 12/2019
1	Length of Stay 01/2019
1	Intraperitoneal Injections 10/2018
1	Percutaneous Coronary Intervention 03/2018
1	Stents 03/2018